Researchers recently found a high prevalence of metabolic syndrome among people with type 2 diabetes and emphasized the efficacy of the uric acid to HDL ratio (UHR) in diagnosing metabolic syndrome. Gholamrerza Bazmandegan, MD, and colleagues conducted a descriptive-analytical study including 300 patients with type 2 diabetes. Using convenient sampling and various statistical methods, researchers collected and analyzed data on demographics, clinical, and laboratory parameters. Results showed that 74.33% of patients had metabolic syndrome. These patients exhibited notably higher UHR (P=0.002) and triglyceride (P<0.001) levels compared to those without metabolic syndrome. The study demonstrated a UHR threshold of 8.118%, with 70.32% sensitivity and 55.08% specificity, for diagnosing metabolic syndrome in patients with type 2 diabetes. Dr. Bazmandegan and colleagues emphasized the importance of regular laboratory monitoring for people with diabetes to identify and manage metabolic syndrome early.
The post Uric Acid to HDL Ratio Useful for Diagnosing Metabolic Syndrome first appeared on Physician's Weekly.